Nitric oxide is a potential down-regulating molecule in autoimmune disease: Inhibition of nitric oxide production renders PVG rats highly susceptible to EAE

Journal of Neuroimmunology

Volumn 88, Issue 1-2, 1998, Pages 1-8

  Cowden, W B ^a   Cullen, F A ^a   Staykova, M A ^b   Willenborg, D O ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b CANBERRA HOSPITAL   (Australia)

Author keywords

EAE; Interferon ; Nitric oxide; NOS inhibitors

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; MYELIN BASIC PROTEIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOWN REGULATION; IMMUNE RESPONSE; LYMPHOID CELL; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL;

ANIMALS; CELL DIVISION; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME INHIBITORS; GENETIC PREDISPOSITION TO DISEASE; INTERFERON TYPE II; LYMPH NODES; MYELIN BASIC PROTEINS; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; OMEGA-N-METHYLARGININE; RATS; RATS, INBRED LEW; RATS, MUTANT STRAINS; SPLEEN;

EID: 0032146845     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00040-X     Document Type: Article

References (43)

1. Abreu, S.L., 1982. Suppression of experimental allergic encephalomyelitis by interferon. Immunol. Commun. 11, 1-7.
2. G-nitro-L-arginine and comparisons to alcohol. Life Sci. 50, PL35-PL40.
3. Albina, J.E., Henry, W.L., 1991. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J. Surg. Res. 50, 403-409.
4. Albina, J.E., Abate, J.A., Henry, W.L., 1991. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation - role of IFN-γ in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147, 144-148.
5. Ben Nun, A., Eisenstein, S., Cohen, I.R., 1982. Experimental autoimmune encephalomyelitis (EAE) in genetically resistant rats: PVG rats resist active induction of EAE but are susceptible to and can generate EAE effector T cell lines. J. Immunol. 129, 918-919.
6. Brunetti, L., Preziosi, P., Ragazzoni, E., Vacca, M., 1993. Involvement of nitric oxide in basal and interleukin-1 β-induced CRH and ACTH release in vitro. Life Sci. 53, L219-L222.
7. Corbett, J.A., Tilton, R.G., Chang, K., Hasan, K.S., Ido, Y., Wang, J.L., Sweetland, M.A. Jr., Sweetland, J.R.L., Williamson, J.R., McDaniel, M.L., 1992. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41, 552-556.
8. Cross, A.H., Misko, T.P., Lin, R.F., Hickey, W.F., Trotter, J.L., Tilton, R.G., 1994. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93, 2684-2690.
9. Deibler, G., Martenson, R., Kies, M., 1972. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2, 139-165.
10. Ding, A.H., Nathan, C.F., Stuehr, D.J., 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141, 2407-2412.
11. Duong, T.T., St. Louis, J., Gilbert, J.J., Finkelman, F.D., Strejan, G.H., 1992. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36, 105-115.
12. Duong, T.T., Finkelman, F.D., Singh, B., Strejan, G.H., 1994. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53, 101-107.
13. Giordano, M., Vermeulen, M., Trevani, A.S., Dran, G., Andonegui, G., Geffner, J.R., 1996. Nitric oxide synthase inhibitors enhance plasma levels of corticosterone and ACTH. Acta Physiol. Scand. 157, 259-264.
14. Gregory, S.H., Wing, E.J., Hoffman, R.A., Simmons, R.L., 1993. Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J. Immunol. 150, 2901-2909.
15. Hooper, D.C., Ohnishi, S.T., Kean, R., Numagami, Y., Dietzschold, B., Koprowski, H., 1995. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA 92, 5312-5316.
16. Hughes, R.A., Stedronska, J., 1973. The susceptibility of rat strains to experimental allergic encephalomyelitis. Immunology 24, 879-884.
17. Isobe, K.I., Nakashima, I., 1992. Feedback suppression of staphylococcal enterotoxin-stimulated lymphocyte-T proliferation by macrophages through inductive nitric oxide synthesis. Infect. Immun. 60, 4832-4837.
18. Iuvone, T., D'Acquisto, F., Carnuccio, R., Rosa, M.D., 1996. Nitric oxide inhibits LPS-induced tumour necrosis factor synthesis in vitro and in vivo. Life Sci. 59, 207-211.
19. Karanth, S., Lyson, K., McCann, S.M., 1993. Role of nitric oxide in interleukin-2-induced corticotropin-releasing factor release from incubated hypothalami. Proc. Natl. Acad. Sci. USA 90, 3383-3387.
20. Krakowski, M., Owens, T., 1996. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26, 1641-1646.
21. Lublin, F.D., Knobler, R.L., Kalman, B., Goldhaber, M., Goldhaber, J., Perrault, M., Dimperio, C., Joseph, J., Alkan, S.S., Korngold, R., 1993. Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 16, 267-274.
22. Ludowyk, P.A., Hughes, W., Hugh, A., Willenborg, D.O., Rockett, K.A., Parish, C.R., 1993. Astrocytic hypertrophy: an important pathological feature of chronic experimental autoimmune encephalitis in aged rats. J. Neuroimmunol. 48, 121-134.
23. MacMicking, J.D., Willenborg, D.O., Weidemann, M.J., Rockett, K.A., Cowden, W.B., 1992. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176, 303-307.
24. Marcinkiewicz, J., Chain, B.M., 1993. Differential regulation of cytokine production by nitric oxide. Immunology 80, 146-159.
25. Mason, D., MacPhee, I., Antoni, F., 1990. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 70, 1-5.
26. Merrill, J.E., Ignarro, L.J., Sherman, M.P., Melinek, J., Lane, T.E., 1993. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151, 2132-2141.
27. Nathan, C.F., Hibbs, J.B., 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3, 65-70.
28. Okuda, Y., Nakatsuji, Y., Fujimura, H., Esumi, H., Ogura, T., Yanagihara, T., Sakoda, S., 1995. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62, 103-112.
29. Ou, P., Wolff, S.P., 1993. Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem. Pharmacol. 46, 1139-1144.
30. G-mono-, di-, and trimethylated arginines. Acta Biochim. Biophys. Acad. Sci. Hung. 12, 191-196.
31. Raber, J., Koob, G.F., Bloom, F.E., 1995. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. J. Pharmacol. Exp. Ther. 272, 815-824.
32. Rivier, C., Shen, G.H., 1994. In the rat, endogenous nitric oxide modulates the response of the hypothalamic-pituitary-adrenal axis to interleukin-1 beta, vasopressin, and oxytocin. J. Neurosci. 14, 1985-1993.
33. Rockett, K.A., Awburn, M.M., Aggarwal, B.B., Cowden, W.B., Clark, I.A., 1992. In vivo induction of nitrite and nitrate by tumour necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria. Infect. Immun. 60, 3725-3730.
34. Rockett, K.A., Awburn, M.M., Rockett, E.J., Cowden, W.B., Clark, I.A., 1994. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol. 16, 243-249.
35. Ruuls, S.R., Vanderlinden, S., Sontrop, K., Huitinga, I., Dijkstra, C.D., 1996. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103, 467-474.
36. Sandi, C., Guaza, C., 1995. Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1β. Eur. J. Pharmacol. 274, 17-23.
37. Scott, G.S., Williams, K.I., Bolton, C., 1996. A pharmacological study on the role of nitric oxide in the pathogenesis of experimental allergic encephalomyelitis. Inflam. Res. 45, 524-529.
38. Taylor Robinson, A.W., Liew, F.Y., Severn, A., Xu, D., McSorley, S.J., Garside, P., Padron, J., Phillips, R.S., 1994. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24, 980-984.
39. Turnbull, A.V., Rivier, C., 1996. Corticotropin-releasing factor, vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local inflammation in the rat. Endocrinology 137, 455-463.
40. Willenborg, D.O., Fordham, S.A., Cowden, W.B., Ramshaw, I.A., 1995. Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol. 41, 31-41.
41. Willenborg, D.O., Fordham, S., Bernard, C., Cowden, W.B., Ramshaw, I.A., 1996. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157, 3223-3227.
42. Zhao, W.G., Tilton, R.G., Corbett, J.A., Mcdaniel, M.L., Misko, T.P., Williamson, J.R., Cross, A.H., Hickey, W.F., 1996. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64, 123-133.
43. Zielasek, J., Jung, S., Gold, R., Liew, F.Y., Toyka, K.V., Hartung, H.P., 1995. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58, 81-88.